Hassan Abduljabbar

By Hassan S.O. Abduljabbar, Samera Al-Basri and Estabrq Al Hachim

The objective: To review all articles published from Saudi Arabia for 18 years to illustrate the complication of abnormal placentation. Materials and methods: In a retrospective study, all publications of placenta previa in our region reviewed. The survey conducted at King Abdulaziz University in J, Saudi Arabia. PubMed, which is a free database search, used to determine the number of publications of placenta previa in Saudi Arabia data collected for 18 years from January 2000 to May 2018. Only (ISI) publication is selected “All abstracts that appeared in the PubMed database collected analyzed meticulously for the year of publication, type of research, institute and the region, and the complication that illustrated in each publication.” The inclusion criteria, as well as exclusion criteria, were clearly defined before the study. The studies defined according to abstract, title, year of publications, the aim, materials and methods, results, and conclusions. Statistical analysis SPSS statistical software (version 22) is used for analysis. Data are coded for numbers and percentages. Results: The number of publication retrieved when we used (placenta previa Saudi Arabia) was 40, but only 19 publications included as for inclusion criteria. Conclusion: Placenta previa is a significant cause of maternal morbidity and mortality. Every hospital must have a clear protocol and a team to manage all cases of placenta previa.

Part of the book: Placenta

By Hassan S.O. Abduljabbar and Abdullah K. Agabawi

The objective is to review the methods of treatment for all cases diagnosed as leiomyoma at Tertiary Teaching Hospital. This is a retrospective study on the medical files of all cases diagnosed as leiomyoma at King Abdulaziz University Hospital. It is a teaching hospital with a capacity of 800 beds in total and 180 beds in the Department of Obstetrics and Gynecology. The study was approved by ethical hospital committee to be performed from July 2016 till September 2018. The total number of admitted cases of Leiomyoma, with a clinical diagnosis and confirmed postoperatively with a histological pathology, were 385. About 244 of Leiomyoma were managed with hysterectomy (63.4%). Open myomectomy was the method of choice to treat 141 cases, which contribute to (36.4%), a different technique used, Hysteroscopic, laparoscopic or open depending on the age of the patients, location, type of leiomyoma and fertility preservation. A number of cases treated with open surgery were 70 out of 141 (49.6%) and laparoscopic myomectomy were 51 out of 141 (36.2%); only 20 cases had hysteroscopic resection of myoma (14.2%). Although hysterectomy is not an acceptable method of treatment for leiomyoma by many patients, still it is the most common surgical method for the treatment of leiomyoma.

Part of the book: Leiomyoma

By Hassan S.O. Abduljabbar, Magda Hagras and Rania Magadmy

A RCT conducted to assess the efficacy of letrozole as an ovulation induction agent in infertile women, and to compare the effectiveness of letrozole with the current standard agent, clomiphene citrate given for three successive cycles on the induction of ovulation. Forty-five infertile women with anovulation included, the subjects were randomly divided into two groups; subjects were allocated to either CC (100) or letrozole (5 mg) daily—5 days starting on the third day of menses, for 3 months. On stimulation day 12 subjects, serum estradiol and transvaginal sonography to document the number of follicles was done. On stimulation day 21 subjects, serum progesterone and ultrasound for the thickness of endometrium was done. Participants were followed-up monthly. Results revealed that the mean number of follicles reaching >18 mm and endometrial thickness in the letrozole comparable to those receiving clomiphene citrate. Letrozole showed lower estradiol level compared to Clomiphene citrate (P < 0.05). Ovulation occurred in 84.4%, 78.1% in the letrozole and clomiphene citrate, respectively, and pregnancy rate is 18.8% in the letrozole group compared to 15% in the clomiphene citrate group. In conclusion, there was no significant increase in the number of follicles, endometrial thickness and pregnancy rate induced by letrozole compared with clomiphene citrate.

Part of the book: Polycystic Ovarian Syndrome